Introduction

CD4
+ T lymphocytes are a key element of adaptive immunity, acting to direct and enhance functions of innate cells, B-cells and CD8 + T-cells in response to diverse pathogens. Following infection, naive CD4 + T-cells proliferate and have the potential to differentiate into at least seven functionally distinct T helper (T H ) subsets with unique effector functions within the circulation, secondary lymphoid organs (SLO) and infected tissues. 1 Depending on the type of immunological threat, early host-pathogen interactions result in an infection milieu that directs differentiation of naive CD4
+ T-cells to acquire the helper functions to ensure that each class of pathogen is countered with the appropriate immune response. 2 Once infection has cleared, the majority of the effector cells die via apoptosis during a contraction phase, while a small proportion persists and differentiates into long-lived memory cells. This memory population enables a rapid and robust secondary response against recurring pathogens and, thus, is pivotal in conferring lasting cellular immunity particularly against pathogens where neutralizing antibodies alone are insufficient at providing long-term protection. While significant advances have been made in understanding the generation and maintenance of memory CD8 + T-cells and B-cells, the molecular mechanisms underlying the generation of memory CD4 + T-cells remain relatively elusive. Two major obstacles have contributed to this knowledge deficit. First, CD4
+ T-cells are inherently less proliferative and the CD4 + memory T-cell population appears to decline following antigen clearance, while the CD8 + memory T-cell population, if established, is typically stable [3] [4] [5] and thus, fewer cells are available for study. Second, the existence of functionally distinct effector T H cell subsets hinders the ability to characterize a common CD4
+ memory T-cell precursor. Further, T H effector and memory T-cells also exhibit significant plasticity and can interconvert between lineages, both in vivo and in vitro, adding an additional layer of complexity to identifying memory precursor cells in CD4 + T memory studies. [6] [7] [8] [9] [10] [11] Memory T-cells have been conventionally divided into central memory (T CM ) cells, which circulate between the blood and SLO, and effector memory (T EM ) cells, which can migrate from the blood into non-lymphoid tissues 1, 11 . Over the past decade, evidence of a novel subset of memory 
I M M U N O L O G Y R E V I E W A R T I C L E cells called tissue-resident memory T-cells (T RM
has emerged. T RM are seeded in non-lymphoid tissues, particularly at barrier sites like the skin and intestinal mucosa. [12] [13] [14] [15] T RM have limited recirculation out of tissues and serve as sentinels at sites of potential reinfection, where they coordinate the initial response to pathogens and provide a substantial boost to tissue immunity via direct antigen recognition and recruitment of circulating immune cells. 13, 16 The majority of studies on T RM have focused on CD8 + tissue-resident lymphocyte differentiation, survival and function, while less is known about their CD4 + counterparts, which are also known to mediate antiviral responses. 17, 18 The relationship between circulating and tissue-resident CD4 + memory T-cell origins and T H effectors subsets is currently unknown. A better understanding of the precursors of CD4 + T RM and the molecular mechanisms mediating their differentiation will allow us to harness the protective capacity of this memory population and modulate their activity in the context of infection or inflammatory diseases.
Despite the challenges in studying memory CD4 + T-cells, efforts in recent years focusing on different aspects of memory development have begun to elucidate a more comprehensive picture for the generation and maintenance of memory CD4 + T-cells. In this review, we summarize recent studies addressing the identity of memory CD4 + T-cell populations and their precursors in both the periphery and non-lymphoid tissues.
CD4
+ T-cell memory in secondary lymphoid organs Despite clear differences between memory CD4 + and CD8 + T-cell populations, including the range of effector cell heterogeneity, 3 the models for memory CD8 + T-cell formation have served as a useful framework for investigation of memory CD4 + T-cells. During the primary response of antigen-specific cytotoxic CD8 + T-cells (CTL), two effector CD8 + T-cell populations can be identified based on surface expression of killer cell lectin-like receptor subfamily G member 1 (KLRG1) and interleukin-7 receptor-a (CD127). 19 21 However, the roles of these molecules in memory CD4 + populations are not well established nor are clear strategies for distinguishing shorter-lived effector and precursors of memory T H populations.
Evidence for long-lived CD4 + memory T-cells capable of responding to pathogen re-challenge has been documented in studies of adoptive transfer of T-cell receptor (TCR) transgenic T-cells [22] [23] [24] [25] 26 
Different individual naive CD4
+ T-cells generated antigen-specific effector populations with varying frequencies of T H 1 and T FH effector cells. Notably, the relative frequencies of these subsets were preserved into the memory phase, suggesting that both T H 1 and T FH effector populations contain precursors of memory cells that retain their effector T H characteristics (Fig. 1a) . These data favour the idea that some CD4 + memory cells are relatively lineage-committed; however, a range of expansion potential and plasticity among progeny was also observed, suggesting that not all CD4 + memory precursor cells may be equivalent. 4 which is why early investigations into T H 2 memory relied on adoptive cell transfers of in vitro polarized T H 2 effectors. 33 This system involved activating CD4 + T-cells in vitro with antigen and antigen-presenting cells (APCs) followed by culturing in T H polarizing conditions 33 and subsequent adoptive transfer. Interestingly, in vitro generated T H 1 and T H 2 cells retained their expression of lineage-defining transcription factors (TFs), T-bet and GATA3, respectively, for months after transfer into naive hosts. 34 However, upon viral infection with LCMV, in vitro-derived T H 2 memory cells were able to adapt a T H 1 phenotype and persist as a 'hybrid' memory cell with combined T H 1 and T H 2 characteristics. 34 Utilizing a similar in vitro polarization system, Endo et al. 35 identified an interleukin-5 (IL-5)-producing subset of T H 2 memory cells in the spleen that is primarily responsible for asthmatic symptoms, such as eosinophilic infiltration into the airway, airway hyper-responsiveness and mucus hyper-production in a murine model of T H 2-driven allergic airway inflammation. These studies provided early evidence of the potential existence of T H 2 memory populations, but data demonstrating direct in vivo generation were lacking until recently.
A study by Hondowicz et al. 36 provided key insights into T H 2 memory studying the endogenous allergen-specific CD4
+ T-cells induced in response to house dust mite (HDM) inoculation. Using pMHCII tetramers to follow antigen-specific CD4 + T-cells, the authors showed an expansion of allergen-specific CD4 + T H 2 cells in SLOs and the lung following intranasal HDM administration. Notably, this allergen system induces both antigen-specific T H 2 and T FH cells, analogous to the T H 1 and T FH response against LCMV-Armstrong. The allergen-specific memory pool in the SLOs consisted of CXCR5 + and CXCR5 À cells that also expressed CCR7 + , consistent with the earlier observations that memory T-cells retain characteristics of T H effector phenotypes . The authors further explored characteristics of allergen-specific T H 2 resident in the lung, which will be discussed in the lung CD4+ T RM section below.
T H 17 CD4 + memory T-cells
Though not as extensively characterized as other helper subsets, memory T H 17 cells have been documented in both humans and mice, primarily in the context of autoimmunity. 37 Early memory experiments using LM 23 However, it is worth noting that LM may not be an optimal infection for T H 17 studies as it is an intracellular pathogen 38 and most efficiently induces T H 1 cells. Muranski et al. 39 reported on long-lived memory T H 17 cells but, similar to early T H 2 studies, these cells required in vitro polarization prior to transfer into host mice. In a recent study of dry eye disease, Chen et al. 40 utilized a pre-clinical murine model of autoimmune ocular disease, where mice were subjected to 14 days of environmental desiccating stress followed by rest in normal conditions for 14 days, and found diseasespecific pathogenic memory T H 17 cells in both the inflamed site and draining lymph nodes. Two cytokines associated with CD4 + memory T lymphocytes, IL-7 and IL-15 41 were shown to be crucial in the maintenance of these pathogenic T H 17 cells. Neutralization of these cytokines with topical application of anti-IL-7 or anti-IL-15 antibody decreased the number of T H 17 cells in both the conjunctivae and lymph nodes, offering a potential therapy for autoimmune disorders. One crucial caveat to note is that these 'memory' T H 17 cells were studied under the chronic inflammatory environment of autoimmunity, perhaps under prolonged or recurrent exposure to antigen; therefore, this population's identity as true resting memory cells remains uncertain.
Uncovering the origin and identity of resting memory or MP cells within a particular helper T-cell lineage will lay the foundation for future molecular studies into how each memory T H lineage is uniquely regulated. However, in the next section, we will review two biological requirements crucial for memory formation that appear to be conserved across all T H subsets.
Memory differentiation cues: TCR signalling and IL-2
A recent comprehensive review of studies aimed at resolving the signals required for CD4 + memory T-cell formation 42 discussed the instructive signals both during the 'early priming' phase of initial antigen recognition and activation as well as at 'late-acting checkpoints' prior to contraction that play a role in the effector-to-memory transition. Much like the signals important for CD8 + memory T-cell generation, strengths of TCR and co-stimulatory signalling also have profound effects on memory T H development. 42, 43 Recent results from Snook et al. 44 demonstrated that TCR signalling has a direct impact on T H memory formation. Utilizing a panel of TCRs specific for the same viral antigen, the authors showed substantial variability in TCR signal strength, expression of IL-2-receptor alpha (CD25) and activation of downstream TFs across the CD4 + memory T-cell population. 44 TCR clones with stronger TCR signalling appear to differentiate towards a more TE state and become largely depleted by memory time points, while clones with comparatively lower signalling were memorylike and able to persist after antigen clearance. Interestingly, it seems that stronger TCR signalling was associated with higher expression of T H 1 markers, while weaker TCR signals correlated with higher expression of T FH markers, 44 suggesting that there may be a connection between lineage differentiation and memory potential for CD4 + helper T-cells. Utilizing influenza A virus (IAV) as an infection model, McKinstry et al. 45 showed that IL-2 is crucial at a late checkpoint for effector helper T-cells to survive the contraction phase, allowing for the transition into resting memory cells. To circumvent defects in initial T-cell priming caused by IL-2 deficiency, the authors first activated CD4
+ T-cells in vitro with exogenous IL-2 and then transferred these cells into naive mice for infection. Following IAV challenge, both in vitro primed wild-type and IL-2-deficient donors showed similar cell numbers at the peak of infection and production of IFNɣ; however, the IL-2-deficient population quickly declined and was undetectable by day 28 of infection. Exogenous administration of IL-2 during days 5-7 of infection successfully restored memory cell numbers for IL-2-deficient CD4 + T-cells, demonstrating the importance of IL-2 for CD4 + memory T-cell generation in this context. Furthermore, a recent study by DiToro et al. 46 with LM infection showed that as early as 20 hr after antigen exposure in vivo, IL-2 production in CD4
+ T H effector cells strongly correlated with T H fate differentiation during infection, again supporting a link between lineage specification and memory formation. To further highlight the importance of IL-2 in T H memory, Shakya et al. 47 identified a role for TF Oct1 and its coactivator OCA-B in poising the Il2 locus for robust expression in memory CD4 + T-cells, unveiling an important mechanism by which memory CD4 + T-cells control IL-2 production. However, these studies regarding TCR signalling and IL-2 in CD4 + memory T-cells were done without investigation of specific T H lineages. Therefore, further investigations into the required transcriptional and epigenetic regulation for generation and maintenance of memory T H subsets are needed. Additionally, while targeting peripheral memory cells in vaccination strategies can provide systemic protection, in some cases a localized strategy in which tissue-resident cells at barrier surfaces are activated as front-line defense against recurrent infections may be more effective, thus how these signals pertain to T RM will be informative. 48 Tissue-resident CD4 + memory T-cells 18, 65, 66 (Fig. 2) . Similar to their CD8 + T-cell counterparts, CD4 + T RM have been shown to facilitate rapid immune defense upon re-exposure to antigen and can supplant innate immunity in recognizing and responding to recurrent infections. 67 However, much remains to be explored about the phenotype, function and maintenance of CD4 + T RM during infections. Additionally, differences exist between CD4 + and CD8 + T RM in tissue localization, surface marker expression and cytokine cues driving T RM formation; these outstanding questions in the field must be addressed to better define the identity and differentiation of CD4 + T RM . Classically, tissue-resident memory T lymphocytes have been defined using parabiosis experiments in which a naive mouse and an immune mouse, previously exposed to antigen, are surgically joined to create a shared circulatory system. 56, 68 Thus, all circulating cells will normalize between both partners while the non-circulating tissueresident cells remain lodged in the tissues of the immune mouse. Alternative methods have been developed and validated to assess whether cells remain in tissues, including intravenous injection of a fluorescently labelled antibody to mark cells in the circulating system. 69 Any cells positive for the label are considered 'circulating', while unlabelled cells are assumed to have limited access to circulation and are therefore 'tissue-resident'. 56 To determine the protective functions of tissue-resident lymphocytes in secondary infection, immune mice are treated with FTY-720, an agonist of sphingosine-1-phosphate receptor 1 (S1PR1), which causes decreased surface expression of S1PR1 and therefore prevents egress of circulating memory cells from lymph nodes. 70 When these mice are re-challenged with the original pathogen, any immune response at the local site of infection will be mediated only by cells resident to that tissue. 71 
Lung CD4 + T RM cells
The lungs contain a population of CD4 + T RM that have been shown to play a critical role in recruiting CD8 + T-cells and enhancing secondary immune responses against bacterial, viral and worm infections. 51, 55, 56, 72 In an influenza infection model, antigen-specific memory CD4 + T-cells migrate to the lungs and are retained in the tissue without recirculation, as demonstrated by parabiosis experiments. 56 This subset of CD4 + T-cells shows a distinct phenotype from circulating populations; specifically, high expression of CD69, a membrane-bound type II C-lectin receptor and known marker of tissue retention. 73, 74 Functionally, these lung-resident CD4 + T-cells provide protection from influenza virus when transferred to naive mice. Similar to its role in directing long-term memory fate as discussed above, IL-2 also supports the formation of antigen-specific lung CD4 + T RM with a transcriptional signature distinct from that of circulating CD4 + T-cell populations but similar to that of CD8 + T RM. 51,75 Interestingly, Strutt et al. 51 also identified an IL-2-independent population of influenza-specific lung CD4 + T RM following infection, suggesting that IL-2 may not be the only cytokine regulating lung T RM development and maintenance. In fact, IL-15 was shown to be essential for these IL-2-independent cells, acting as an 'alarm' at local sites of infection to promote both CD8 + T-cell responses and induce long-lived CD4 + T RM.
42,51
Using fluorescently labelled antibody injection, Hondowicz et al. 49 showed that LCMV-specific CD4 + T-cells migrated to the lungs as a Tbet hi T H 1 subset with CD69 expression similar to influenza experiments. Again, the establishment of LCMV-specific lung T H 1 T RM cells required IL-2 signalling; however, for long-term maintenance and survival, additional interactions with B-cells in tissues were necessary. 49 Several groups have shown that allergens in an asthma model also elicit CD4 + T RM responses in the lung. After exposure to HDM, allergen-specific CD4 + T RM in the lungs were shown to be resident by parabiosis experiments. 36 These cells expressed high levels of CD69 and required IL-2 signalling for their migration to the lungs, similar to the studies above with viral pathogens. Interestingly, the TF Bcl6, the fate-determining factor for T FH cells, prevented HDM-specific CD4 + T RM from entering the lungs, and loss of Bcl6 actually increased the T RM population in the tissue. These results suggest a possible antagonistic relationship between T RM and memory T FH cells, and highlight a role for TFs in directing the development of tissue-resident populations. In another study using the HDM model, lung CD4 + T RM clustered around the airways at rest and rapidly reactivated upon secondary exposure within their clusters to produce IL-4, IL-5 and IL-17 and recruit dendritic cells. 50 Additional studies highlight a role for IL-7, along with IL-2, in the maintenance of allergen-specific CD4 + T RM cells in the lung parenchyma and airways. However, these IL-7-dependent CD4 + T RM did not express CD69, 52 suggesting either that CD69 may not be a conclusive marker for CD4 + T RM or that CD4 + T RM are highly heterogeneous, and further studies must focus on elucidating the different subsets. Additionally, in both viral infection and allergen-induced asthma models, it remains unclear whether the same cells can become resident in both the parenchyma and airways, and if similar survival signals sustain such subsets. 15 using intravital microscopy demonstrated that HSV-specific gDT-II CD4 + T-cells showed a migration pattern distinct from that of CD8 + T-cells in the skin following infection, homing to the dermis as opposed to the preference of CD8 + T-cells for the epidermis. Additionally, dermal T H cells were significantly more motile and had lower expression of CD103 compared with CD8 + T-cells. Thus, it appears that CD4 + T RM can migrate between the skin and circulation much more easily than CD8 + T RM and may not be a fully resident population. In another study of skin HSV response, Collins et al. examined skin from naive mice and found resting CD4 + T-cells preferentially clustered around hair follicles. Upon infection, circulating CD4 + T-cells were rapidly recruited to the skin, specifically to the perifollicular regions; the majority of recruited cells were lost by day 30, but a small percentage survived in tissue long after initial antigen exposure. 64 These skin CD4
+ T RM , as demonstrated by parabiosis experiments, also aggregated in APC-associated clusters, consistent with experiments done in the FRT, 66, 76 as discussed below. Additional studies of skin CD4 + T RM following Leishmania major (L. major) infection showed evidence of a L. major-specific resident population in the dermis with increased expression of IFN genes and chemokine signalling pathways. 61 These CD4 + T RM cells were able to control parasite growth following a secondary challenge, presumably through the aforementioned IFN response and recruitment of circulating immune cells. Through FTY-720 treatment experiments, resident CD4 + T-cells were found to be the main contributors to protection against L. major, recruiting inflammatory monocytes for production of reactive oxygen species to kill the parasites. 62 These results highlight another function of CD4 + T-cells, though no parabiosis experiment has been performed to definitively characterize this population as resident. In general, intestinal helper T-cells can be found as both intraepithelial lymphocytes (IELs) and lamina propria lymphocytes (LPLs) with a greater proportion of cells in the LP. The majority of studies of gut-resident CD4 + T-cell subsets have focused on endogenous polyclonal IELs that originate from the circulating population. 59, 78, 79 Upon entering the SI, these CD4 + IELs downregulate the TF ThPOK responsible for thymic CD4 + T-cell fate and upregulate Runx3, the fate-determining factor for differentiating CD8 + thymocytes. This switch in programming towards a more cytolytic function appears to be important in the CD4 + T-cell response to endogenous gut microbiota. 78 Nevertheless, this study characterizes polyclonal CD4 + T-cells with variable TCR specificity and affinity, and further investigations are necessary to determine whether similar transcriptional changes are seen in antigen-specific responses. In an LM infection, antigen-specific CD4 + T-cells preferentially migrated into the LP (though a small population was seen in the IEL) to form a long-lived antigen-specific memory population that was predominantly T H 1, expressed high levels of CD69 and, unlike lung-resident CD4 + T-cells, was independent of IL-15 signalling. 60 Interestingly, this gut 'T RM ' population had low Ly6C expression relative to other lymphocytes in circulation, similar to the MP population of circulating T H 1 cells discussed in the T H 1 and T FH CD4+ memory T-cells above. This suggests that circulating and resident memory cells may share a common precursor. As discussed in the studies above, CD4 + T RM differ greatly between infection models and tissues, although some general principles can be drawn (Fig. 2) . As is the case with CD8 + T RM , the majority of CD4 + T RM express high levels of CD69, but CD103 expression varies within and between tissues. 15, 56, 60, 66 Across multiple tissues -lung, skin, FRT -CD4 + T RM form clusters with other resident immune subsets including CD8 + Tcells, macrophages and APCs. 52, 64, 66 These clusters position CD4 + T RM in close proximity to the cells they need to activate in case of a recurrent infection. This may be an optimized way for helper T RM cells to perform their 'sense-and-alarm' function, 68 initiating the innate response to recruit circulating cells and activating CD8 + T-cells to fight off pathogen. Additionally, cytokines appear to be critical in the recruitment, formation and maintenance of CD4 + T RM in many tissues. [50] [51] [52] 60 However, which cytokines are important for which tissues remain unknown, although IL-2 may play a key role for all T RM given its known effects in circulating memory populations. 80 It is also unclear which CD4 + T H effector subset, if any, gives rise to T RM , or whether the tissue-resident precursor is distinct from the peripheral population completely, residing in the tissue until the right signals are detected to induce differentiation.
Conclusion
The diversity and plasticity of effector CD4 + T-cells create a heterogeneous memory pool, making the study of helper T-cell memory differentiation complex. While there are some promising markers to differentiate between memory T H 1 and T FH memory subsets, 24, 27 it is still unclear whether both helper memory populations originate from their respective effector cells or whether the 'stem-like' properties of T FH cells make them the primary precursor. 25 Likewise, in other infection systems that elicit T H 2 or T H 17 effector cells, we do not know how these effector populations contribute to the final pool of memory cells. Adding further to the complexity, CD4
+ T RM cells are highly variable across tissues, and different cues drive their establishment and retention. It is unclear whether the precursor for CD4 + T RM cells originates from the same memory-precursor population that yields circulating memory cells or if it is found even earlier, before the effector versus memory decision. T FH cells may also contribute to the CD4 + T RM pool, although currently no evidence exists for a T FH -like subset in tissues. Lastly, it is clear that surface markers do not accurately identify subpopulations in effector and memory pools, and further work requires examining TFs and regulators that may direct the memory programme. One possible approach to parse the heterogeneity of CD4 + memory T-cells is through bulk and single-cell epigenetic and transcriptional profiling of cells in the circulation and tissues over the course of an infection to identify whether an early memory precursor exists or whether memory potential is programmed as effector cells contract and die. 75, 81, 82 Paired with adoptive transfers of putative subsets, it will be possible to identify key factors at each step in the effector-to-memory transition, and in the formation and survival of the tissue-resident subset.
